NKTR – Nektar Therapeutics
Float Short %
6
Margin Of Safety %
Put/Call OI Ratio
0.68
EPS Next Q Diff
-0.17
EPS Last/This Y
-2.36
EPS This/Next Y
-0.95
Price
48.72
Target Price
96.17
Analyst Recom
1.75
Performance Q
455.71
Relative Volume
0.39
Beta
-1.17
Ticker: NKTR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-08-15 | NKTR | 27.3 | 0.27 | 0.04 | 74650 |
| 2025-08-18 | NKTR | 27.42 | 0.60 | 0.55 | 25368 |
| 2025-08-19 | NKTR | 26.78 | 0.60 | 0.44 | 26253 |
| 2025-08-20 | NKTR | 26.95 | 0.60 | 1.23 | 26439 |
| 2025-08-21 | NKTR | 28 | 0.60 | 0.23 | 26463 |
| 2025-08-22 | NKTR | 27.07 | 0.60 | 0.45 | 26800 |
| 2025-08-25 | NKTR | 27.2 | 0.60 | 0.15 | 26987 |
| 2025-08-26 | NKTR | 28.76 | 0.61 | 2.23 | 27072 |
| 2025-08-27 | NKTR | 29.28 | 0.63 | 0.50 | 27747 |
| 2025-08-28 | NKTR | 29.31 | 0.63 | 0.01 | 27871 |
| 2025-08-29 | NKTR | 29.84 | 0.61 | 4.51 | 28406 |
| 2025-09-02 | NKTR | 29.06 | 0.64 | 0.19 | 28918 |
| 2025-09-03 | NKTR | 28.53 | 0.63 | 0.22 | 29013 |
| 2025-09-04 | NKTR | 35.94 | 0.63 | 0.27 | 29711 |
| 2025-09-05 | NKTR | 40.1 | 0.70 | 2.61 | 31649 |
| 2025-09-08 | NKTR | 44.3 | 0.72 | 0.31 | 33822 |
| 2025-09-09 | NKTR | 48.55 | 0.69 | 0.92 | 37743 |
| 2025-09-10 | NKTR | 48.16 | 0.73 | 0.14 | 39099 |
| 2025-09-11 | NKTR | 47.13 | 0.68 | 0.39 | 41299 |
| 2025-09-12 | NKTR | 48.84 | 0.68 | 0.23 | 43228 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-08-15 | NKTR | 27.27 | 1.4 | - | -10.68 |
| 2025-08-18 | NKTR | 27.47 | -14.0 | - | -10.68 |
| 2025-08-19 | NKTR | 26.72 | -14.0 | - | -10.68 |
| 2025-08-20 | NKTR | 26.96 | -14.0 | - | -10.68 |
| 2025-08-21 | NKTR | 27.92 | -14.0 | - | -10.68 |
| 2025-08-22 | NKTR | 27.04 | -14.0 | - | -10.68 |
| 2025-08-25 | NKTR | 27.17 | -14.0 | - | -10.68 |
| 2025-08-26 | NKTR | 28.78 | -14.0 | - | -10.68 |
| 2025-08-27 | NKTR | 29.28 | -14.0 | - | -10.68 |
| 2025-08-28 | NKTR | 29.34 | -14.0 | - | -10.68 |
| 2025-08-29 | NKTR | 29.80 | -14.0 | - | -10.68 |
| 2025-09-02 | NKTR | 29.08 | -5.5 | - | -11.06 |
| 2025-09-03 | NKTR | 28.53 | -5.5 | - | -11.06 |
| 2025-09-04 | NKTR | 35.93 | -5.5 | - | -11.06 |
| 2025-09-05 | NKTR | 40.18 | -5.5 | - | -11.06 |
| 2025-09-08 | NKTR | 44.33 | -5.5 | - | -11.06 |
| 2025-09-09 | NKTR | 48.55 | -5.5 | - | -11.06 |
| 2025-09-10 | NKTR | 48.15 | -5.5 | - | -11.06 |
| 2025-09-11 | NKTR | 47.20 | -5.5 | - | -11.06 |
| 2025-09-12 | NKTR | 48.72 | -5.5 | - | -11.06 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-08-15 | NKTR | -15.51 | 43.42 | 5.54 |
| 2025-08-18 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-19 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-20 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-21 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-22 | NKTR | -8.82 | 31.02 | 5.54 |
| 2025-08-25 | NKTR | -8.82 | 12.41 | 5.54 |
| 2025-08-26 | NKTR | -8.82 | 12.41 | 5.53 |
| 2025-08-27 | NKTR | -8.82 | 12.41 | 5.58 |
| 2025-08-28 | NKTR | -8.85 | 12.41 | 5.58 |
| 2025-08-29 | NKTR | -8.85 | 12.41 | 5.58 |
| 2025-09-02 | NKTR | -8.85 | 12.34 | 5.58 |
| 2025-09-03 | NKTR | -8.85 | 12.34 | 5.58 |
| 2025-09-04 | NKTR | -8.85 | 12.34 | 5.58 |
| 2025-09-05 | NKTR | -9.19 | 12.34 | 5.58 |
| 2025-09-08 | NKTR | -9.19 | 12.34 | 5.58 |
| 2025-09-09 | NKTR | -11.44 | 12.34 | 5.58 |
| 2025-09-10 | NKTR | -11.48 | 12.34 | 5.58 |
| 2025-09-11 | NKTR | -11.48 | 12.34 | 6.02 |
| 2025-09-12 | NKTR | -12.56 | 12.34 | 6.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.95
Avg. EPS Est. Current Quarter
-2.8
Avg. EPS Est. Next Quarter
-3.12
Insider Transactions
-12.56
Institutional Transactions
12.34
Beta
-1.17
Average Sales Estimate Current Quarter
10
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
25
Growth Score
23
Sentiment Score
92
Actual DrawDown %
87.9
Max Drawdown 5-Year %
-98.3
Target Price
96.17
P/E
Forward P/E
PEG
P/S
12.36
P/B
P/Free Cash Flow
EPS
-8.72
Average EPS Est. Cur. Y
-11.06
EPS Next Y. (Est.)
-12.02
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-163.17
Relative Volume
0.39
Return on Equity vs Sector %
480.2
Return on Equity vs Industry %
493.3
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-1.05
EBIT Estimation
Nektar TherapeuticsSector: Healthcare
Industry: Biotechnology
Employees: 61
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
stock quote shares NKTR – Nektar Therapeutics Stock Price stock today
news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025
marketwatch NKTR – Nektar Therapeutics yahoo finance google finance
stock history NKTR – Nektar Therapeutics invest stock market
stock prices NKTR premarket after hours
ticker NKTR fair value insiders trading